NCT07199738View on ClinicalTrials.gov

A Multi-Center Study Assessing the Safety and Efficacy of the LEGION Medial Stabilized (MS) Insert in Patients Undergoing a Total Knee Arthroplasty (TKA)

Not yet recruitingOBSERVATIONAL
Enrollment

144

Participants

Timeline

Start Date

November 30, 2025

Primary Completion Date

December 31, 2036

Study Completion Date

December 31, 2036

Conditions
Inflammatory ArthritisPrimary Total Knee Arthroplasty Due to Degenerative Joint Disease (Primary Diagnosis of Osteoarthritis)Post-traumatic Arthritis
Interventions
DEVICE

Cemented CoCr

Primary TKA performed using the LEGION MS with Cemented Tibia (JII) with LEGION CR non-porous (CoCr) Femoral component

DEVICE

Cemented Oxinium

Primary TKA performed using the LEGION MS with Cemented Tibia (JII) with LEGION CR non-porous (Ox) Femoral component

DEVICE

Cementless

Primary TKA performed using the LEGION MS with CONCELOC Tibia with LEGION CR porous (without HA) Femoral component

Trial Locations (6)

10016

New York University Hospital, New York

29425

Medical University of South Carolina, Charleston

32803

Rothman Orthopedics-Advent Health, Orlando

85023

The Core Institute, Phoenix

02462

Newton Wellesley Hospital, Newton

53715-1218

University of Wisconsin, Madison

All Listed Sponsors
lead

Smith & Nephew, Inc.

INDUSTRY

NCT07199738 - A Multi-Center Study Assessing the Safety and Efficacy of the LEGION Medial Stabilized (MS) Insert in Patients Undergoing a Total Knee Arthroplasty (TKA) | Biotech Hunter | Biotech Hunter